Search Results for: crispr

Weekly reads: Marc Tessier-Lavigne probe, Neuralink on the brain, Ras unchained

/ / Leave a Comment
Marc Tessier-Lavigne

We’ll start with a story related to possible research misconduct, Stanford’s President Marc Tessier-Lavigne, and Science Magazine.  In some ways the news on Science itself could be the bigger long-term story. Marc Tessier-Lavigne pub investigation, Science oops moment Here’s some of the coverage: Stanford investigates potential misconduct in president’s research, Science. Multiple publications of Marc Tessier-Lavigne […]

Weekly reads: Marc Tessier-Lavigne probe, Neuralink on the brain, Ras unchained Read More »

What is Mastodon & why so far it’s a clunky alternative to Twitter

/ / 4 Comments
Mastodon

Lately it seems like something called Mastodon is on the minds of many a Twitter user. There is a wave of people tweeting “let’s dump Twitter and go to Mastodon now that Musk has taken over!” However, so far I don’t see Mastodon as a solid alternative to the admittedly annoyingly musky Twitter. I do

What is Mastodon & why so far it’s a clunky alternative to Twitter Read More »

Funny autocorrect fails in STEM: the gremlin organdy fiasco

/ / Leave a Comment
Germline gremlins, funny autocorrect fails

Today’s post is on the lighter side with some humor on funny autocorrect fails related to science. It’s surprising sometimes how far certain tools can lag behind cutting-edge science. Spellcheck tools are useful, of course, but they don’t always know what to do with STEM words. The same is true of tools like Grammarly, although it

Funny autocorrect fails in STEM: the gremlin organdy fiasco Read More »

‘We don’t want to freak people out’: about that Jacob Hanna human embryo model startup

/ / 5 Comments
Jacob Hanna Renewal Bio

Stem cell biologist Jacob Hanna has a new startup called Renewal Bio. Its goal is to harvest cells or tissues from human embryo or fetus models for clinical use. I believe that their commercial ambitions have so far outstripped careful thought and discussion in the broader community of researchers. There are major risks here for

‘We don’t want to freak people out’: about that Jacob Hanna human embryo model startup Read More »

Weekly reads: fibroblasts, gene-editing, Mitalipov, personhood, embryos

/ / 1 Comment
NIH 3T3 fibroblasts ATCC

I have a soft spot for fibroblasts, perhaps because one of the first immortalized cell lines I ever grew was NIH3T3. These are mouse fibroblasts that have been immortalized. They are very useful for a variety of experiments. I used them to study an oncogene called E2A-PBX1. Experience with fibroblasts including 3T3s I was amazed

Weekly reads: fibroblasts, gene-editing, Mitalipov, personhood, embryos Read More »

Weekly stem cell reads: space, plagiarism, HIV, diabetes, more

/ / Leave a Comment
blood stem cell biology

I took a cross-country road trip earlier this month that was pretty amazing and barely thought about stem cell research for the first time in years. We did run across one stem cell clinic in Florida by accident. I’ll write about that trip soon, but first we have our weekly reads including some very cool

Weekly stem cell reads: space, plagiarism, HIV, diabetes, more Read More »

Weekly reads: Jan Nolta recognition, new director after Irv, FDA guidance

/ / 2 Comments
Dr. Jan Nolta UC Davis

People are the real driving force in the stem cell and regenerative medicine field including my colleague Jan Nolta here at UC Davis. She is the Director of our Stem Cell Program. There’s also news about Stanford’s stem cell Director Irv Weissman. Jan Nolta receives award Jan’s lab is prolific and in many ways is

Weekly reads: Jan Nolta recognition, new director after Irv, FDA guidance Read More »